Five Takeaways About the Wild — and Evolving — Cash-Pay Market for Obesity Meds

There may be no drug-pricing myth more pernicious than the idea that the NIH does all the drug research, and companies just sweep in at the eleventh hour, ram medicines

I’m back -- 100% back -- from last week, where I was super-sick on Wednesday, rallied for a 6 a.m. flight the next day, and closed on my new home

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv. We’re not done with smoothing